Dr. Christopher Nicholaus Roclevitch is a Houston, Texas based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 4828 Old Spanish Trl # A, Houston. Patients can reach him at 210-789-1101.
Dr. Christopher Nicholaus Roclevitch deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Christopher Nicholaus Roclevitch speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Christopher Nicholaus Roclevitch
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
DDS
Accepts Medicare Assignment:
May Accept
Practice Address:
4828 Old Spanish Trl # A, Houston, Texas, 77021-1721
Phone:
210-789-1101
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
8325347131
Enrollment ID:
I20160429000393
NPI Number:
1508232992
NPI Enumeration Date:
19 Aug, 2015
NPI Last Update On:
10 Dec, 2023
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6329 Oram St, Dallas, Texas
Zip:
75214-3931
Phone Number:
214-823-1638
Fax Number:
214-823-1169
Patients can reach Dr. Christopher Nicholaus Roclevitch at 4828 Old Spanish Trl # A, Houston, Texas or can call to book an appointment on 210-789-1101. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.